Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Acyl coenzyme A:cholesterol acyltransferase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma mansoni | sterol O-acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus multilocularis | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma japonicum | ko:K00637 sterol O-acyltransferase [EC2.3.1.26], putative | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus granulosus | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Dictyostelium discoideum | diacylglycerol O-acyltransferase 1 | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 547 aa | 22.3 % |
Neospora caninum | sterol O-acyltransferase, putative | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 510 aa | 21.2 % |
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 510 aa | 24.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0295 | 1 | 1 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.021 | 0.6827 | 1 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0026 | 0 | 0.5 |
Echinococcus granulosus | dihydrofolate reductase | 0.0086 | 0.2217 | 0.2511 |
Brugia malayi | dihydrofolate reductase family protein | 0.0086 | 0.2217 | 0.3248 |
Echinococcus multilocularis | thymidylate synthase | 0.021 | 0.6827 | 0.773 |
Treponema pallidum | alginate O-acetylation protein (algI) | 0.0026 | 0 | 0.5 |
Loa Loa (eye worm) | thymidylate synthase | 0.021 | 0.6827 | 0.773 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0036 | 0.0397 | 0.045 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0086 | 0.2217 | 0.2511 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0086 | 0.2217 | 0.5 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0026 | 0 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.021 | 0.6827 | 0.773 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0295 | 1 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0086 | 0.2217 | 0.2511 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0086 | 0.2217 | 0.2511 |
Mycobacterium tuberculosis | Hypothetical protein | 0.01 | 0.2746 | 0.1148 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0036 | 0.0397 | 0.045 |
Schistosoma mansoni | sterol O-acyltransferase 1 | 0.0264 | 0.8831 | 1 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0026 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.01 | 0.2746 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.0521 | 0.059 |
Brugia malayi | Dihydrofolate reductase | 0.0086 | 0.2217 | 0.3248 |
Onchocerca volvulus | 0.021 | 0.6827 | 1 | |
Echinococcus granulosus | sterol O acyltransferase 1 | 0.0264 | 0.8831 | 1 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0295 | 1 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.021 | 0.6827 | 0.773 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0295 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0264 | 0.8831 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.0308 | 0.1122 |
Brugia malayi | hypothetical protein | 0.01 | 0.2746 | 0.4023 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0295 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.0521 | 0.059 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0036 | 0.0397 | 0.0582 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.0308 | 0.1122 |
Mycobacterium ulcerans | thymidylate synthase | 0.021 | 0.6827 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0026 | 0 | 0.5 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0036 | 0.0397 | 0.045 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.021 | 0.6827 | 1 |
Echinococcus multilocularis | sterol O acyltransferase 1 | 0.0264 | 0.8831 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0218 | 0.0247 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0026 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.7875 | 0.8918 |
Entamoeba histolytica | vacuolar protein sorting 26 | 0.0026 | 0 | 0.5 |
Brugia malayi | thymidylate synthase | 0.021 | 0.6827 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.01 | 0.2746 | 0.2746 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.05 uM | In vitro inhibition of Acyl coenzyme A:cholesterol acyltransferase in rat hepatic microsomes | ChEMBL. | 7932580 |
IC50 (binding) | = 0.05 uM | In vitro inhibition of Acyl coenzyme A:cholesterol acyltransferase in rat hepatic microsomes | ChEMBL. | 7932580 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.